A 62-year-old man had an anterior ST elevation myocardial infarction 3 months ago and received a coronary stent. He is now clinically stable, on dual antiplatelet therapy and a beta blocker but no lipid-lowering therapy. His fasting LDL cholesterol is 3.6 mmol/L. Which lipid-lowering regimen is most appropriate for secondary prevention?